Extremely high infiltration of CD8<sup>+</sup>PD-L1<sup>+</sup> cells detected in a stage III non-small cell lung cancer patient exhibiting hyperprogression during anti-PD-L1 immunotherapy after chemoradiation: A case report. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.